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Abstract
 
The mechanisms underlying CD4
 
  
 
T cell depletion in human immunodeficiency virus (HIV)
infection are not well understood. Comparative studies of lymphoid tissues, where the vast majority
of T cells reside, and peripheral blood can potentially illuminate the pathogenesis of HIV-associated
disease. Here, we studied the effect of HIV infection on the activation and depletion of defined
subsets of CD4
 
  
 
and CD8
 
  
 
T cells in the blood, gastrointestinal (GI) tract, and lymph node
(LN). We also measured HIV-specific T cell frequencies in LNs and blood, and LN collagen
deposition to define architectural changes associated with chronic inflammation. The major
findings to emerge are the following: the GI tract has the most substantial CD4
 
  
 
T cell depletion
at all stages of HIV disease; this depletion occurs preferentially within CCR5
 
  
 
CD4
 
  
 
T cells;
HIV-associated immune activation results in abnormal accumulation of effector-type T cells
within LNs; HIV-specific T cells in LNs do not account for all effector T cells; and T cell acti-
vation in LNs is associated with abnormal collagen deposition. Taken together, these findings
define the nature and extent of CD4
 
  
 
T cell depletion in lymphoid tissue and point to mecha-
nisms of profound depletion of specific T cell subsets related to elimination of CCR5
 
  
 
CD4
 
  
 
T
cell targets and disruption of T cell homeostasis that accompanies chronic immune activation.
Key words: HIV pathogenesis • CD4
 
 
 
 T cell depletion • lymph nodes • gastrointestinal tract • 
HIV-speciﬁc T cells
 
Introduction
 
The depletion of CD4
 
  
 
T cells, the hallmark of HIV-1 infec-
tion, has largely been studied in the most accessible com-
partment, peripheral blood, to understand the mechanisms
of this depletion, follow progression of infection, and deter-
mine the time to initiate antiretroviral therapy (1). However,
for the reasons outlined below, we believe studies of lym-
phoid tissue are likely to prove more rewarding in an effort
to better understand why CD4
 
  
 
T cells are depleted, and
thereby will enable a more rationally timed antiretroviral
therapy. First, most CD4
 
  
 
T cells reside within the gas-
trointestinal (GI) tract, LNs, and other lymphatic tissues
rather than in peripheral blood (2). Second, there are large
numbers of target cells in the GI tract that express CCR5,
the HIV coreceptor for entry (3–7). Third, lymphoid tissue
has been identified as a major site of HIV replication and a
reservoir for HIV in vivo (8–15).
Indeed, both viral cytopathic effects and CTL killing of
infected target cells could contribute to the depletion of
CD4
 
  
 
T cells from lymphoid tissue. In fact, substantial
numbers of HIV or simian immunodeficiency (SIV)-specific
CD8
 
  
 
T cells reside within the GI tract of HIV/SIV-infected
individuals (16–20) and there is one report suggesting that
LNs contain a greater breadth of HIV-specific CD8
 
  
 
T
cells than peripheral blood (21). The relationship between
infection of target cells and the cellular immune response is
not clear, but it is known that host defenses do not prevent
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the nearly complete depletion of CD4
 
  
 
T cells in the GI
tract of SIV-infected macaques as early as 2 wk after infec-
tion (5, 6, 22, 23), or the loss of intestinal CD4
 
  
 
T cells
from the early to later stages of HIV-1 infection (24–27).
Such lymphoid tissues are also likely to play an important
role in the maintenance of CD4 T cell numbers through-
out HIV infection. Indeed, the fibrosis and architectural
disorganization documented in LN biopsies from HIV-
infected individuals, which may reflect chronic inflamma-
tory responses associated with viral replication, are likely to
affect CD4
 
  
 
T cell homeostasis. This is underscored by the
highly significant correlation between collagen deposition,
CD4
 
  
 
T cell depletion (28), and CD4
 
  
 
T cell repletion
(unpublished data) on antiretroviral therapy.
Collectively, these studies suggest that a full understand-
ing of the mechanisms relating to CD4
 
  
 
T cell depletion
and disease progression will likely require direct analysis of
viral infection, the immune response, immune activation
and pathology in lymphoid tissue compartments, and the
relationship of the dynamics of infection in lymphoid tis-
sue to peripheral blood. However, to date there have been
no studies that directly compare T cell depletion, activa-
tion, or phenotypic composition in peripheral blood, LNs,
and the GI tract from HIV-infected and -uninfected indi-
viduals. Here, we recruited 14 treatment-naive, HIV-
infected individuals at different disease stages and 7 HIV-
uninfected individuals and sampled inguinal LNs, ileal
Peyer’s patches and lamina propria, and venous blood.
From each subject and within each compartment we ex-
amined (a) CD4
 
  
 
T cell depletion; (b) relative levels of na-
ive, effector–memory and central memory CD4
 
  
 
and
CD8
 
  
 
T cells; (c) T cell activation based upon CCR5 and
Ki67 expression; (d) the magnitude of HIV-specific CD4
 
 
 
and CD8
 
  
 
T cell responses; and (e) LN collagen composi-
tion. Taken together, our data reveal fundamental mecha-
nisms underlying T cell depletion and disease progression
in HIV-infected individuals.
 
Materials and Methods
 
Subjects.
 
14 antiretroviral therapy–naive, HIV-infected and 7
HIV-uninfected, sexually active subjects that were high risk of
becoming HIV
 
  
 
were recruited for this study. Clinical details are
shown in Table I. HIV
 
  
 
individuals were classified as “early”
based on HIV seropositivity for 
 
 
 
1 yr with maintained CD4
counts of 
 
 
 
300, “chronic” based on seropositivity for 
 
 
 
1 yr
with CD4 counts 
 
 
 
200, and “AIDS” based on a CD4 count of
 
 
 
200 regardless of the duration of infection. HIV
 
  
 
individuals
were classified as long-term nonprogressors based on HIV infec-
tion of 
 
 
 
5 yr without declines of blood CD4
 
  
 
T cell counts and
viral loads 
 
 
 
5,000 copies/ml of plasma. Viral load was deter-
mined using either the Roche Amplicor Monitor assay or the
Roche Ultradirect assay. The subjects all gave informed consent
in compliance with the appropriate institutional review boards.
 
Samples.
 
PBMCs were prepared from venous blood by den-
sity gradient centrifugation. Ileal Peyer’s patches and lamina pro-
pria samples were acquired by endoscopy and biopsy of the ter-
minal ileum. Patients received standard colonoscopy preparation
and were sedated with versed and fentanyl. A colonoscope was
passed through the large intestine and through the ileo–cecal
valve. At least 8–10 biopsy samples were obtained with cold for-
ceps using standard techniques. Four of the tissue samples were
placed into formalin for histopathologic analysis and the remain-
ing samples were placed into normal saline and kept on ice until
digestion. Inguinal LNs were obtained as described previously
(28). GI tract and LN samples were then dissected into 100-
 
 
 
L
fragments and were digested in Iscove’s media supplemented
with 2 mg/ml Type II collagenase (Sigma-Aldrich) and 1 U/ml
DNase I (Sigma-Aldrich) for 30 min at 37
 
 
 
C. After digestion,
samples were passed through a 100-
 
 
 
m filter and were washed
twice with RPMI media supplemented with 10% heat-inacti-
vated fetal calf serum (R10; Sigma-Aldrich).
 
Flow Cytometric Analysis.
 
Six-parameter flow cytometric
analysis was performed using a FACSCalibur flow cytometer
(Becton Dickinson). FITC, PE, peridin-chlorophyll protein (PerCP),
and allophycocyanin (APC) were used as the fluorophores. At
least 300,000 live lymphocytes were collected. The list-mode
data files were analyzed using FlowJo (Tree Star Inc.).
 
HIV-specific T Cell Assay.
 
Stimulation was performed on fresh
or frozen PBMCs as described elsewhere (29). Freshly isolated or
freshly thawed PBMCs were resuspended at 10
 
6
 
/ml in R10 sup-
plemented with 1 
 
 
 
g/ml anti-CD28 and anti-CD49d antibodies.
Peptides 15 amino acids in length, overlapping by 11 amino acids
and encompassing HIV-1 gag, pol, and env (corresponding to the
sequence of HXBc2), were used to stimulate HIV-specific T cells
in the presence of 1 
 
 
 
g/ml brefeldin A (Sigma-Aldrich) for 5 h at
37
 
 
 
C. All cells were surface stained for phenotypic markers of in-
terest and intracellularly stained for cytokines.
 
Table I.
 
Subject Cohort 
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Monoclonal Antibodies, Tetrameric Complexes, and T Cell Pheno-
typing.
 
The following monoclonal antibodies were used for
phenotypic and functional characterization of T cell subsets: anti-
CD3 PerCP, anti-CD45RO FITC, anti-CD27 PE, anti-CD4
PerCP or PE, anti-CD8 APC or PerCP, anti-CCR5 PE, anti-
Ki67 FITC, and anti–IFN-
 
  
 
APC and anti–IL-2 APC (Becton
Dickinson). As very few, if any, naive T cells express the activa-
tion markers Ki67 and CCR5, and as HIV-specific T cells are not
detectable in the naive T cell pool, we report these data as per-
centages of memory T cells. We first determine the percentage of
memory CD4
 
  
 
and CD8
 
  
 
T cells based upon characteristic ex-
pression patterns of CD45RO and CD27. We then separately
determine the percentage of CD4
 
  
 
and CD8
 
  
 
T cells that express
Ki67 or CCR5 or are HIV specific. The percentage of a defined
population that are memory T cells is calculated by dividing the
percentage of total T cells within that defined population by the
fraction that are memory. The following tetrameric complexes
were used to examine the frequency of HIV-specific CD8
 
  
 
T cells:
HLA-B57 KAFSPEVIPMF, HLA-A2 SLYNTVATL, HLA-B8
GGKKKYKL, and HLA-B8 FLKEKGGL.
 
Collagen Deposition.
 
Levels of collagen deposition within in-
dividual LN samples were determined as described previously
(28). To identify collagen fibers, 5-
 
 
 
M sections were cut from
the baseline tissue and stained with a trichrome stain using the
Masson method. 18 images were obtained from the T cell zone
of each tissue sample and imported into Adobe Photoshop 6.0.
The color sampler tool was used to analyze representative shades
and hues of the blue-stained collagen tissue. The area of the field
containing collagen was selected and the background tissue was
removed from the image. Collagen tissue was translated into a
uniform color and the image was transferred into the Metamorph
software (Universal Imaging) program to determine the percent
area of tissue occupied by collagen as described previously (28).
 
Statistical Analysis.
 
Spearman’s rank correlation, Wilcoxon
matched pairs tests, and Mann-Whitney tests were performed us-
ing Prism 4.0 software.
 
Results
 
Comparative Analysis of CD4
 
  
 
T Cell Percentages in the GI
Tract, LNs, and Peripheral Blood of HIV
 
  
 
and HIV
 
  
 
Individu-
als.
 
As it has been shown previously that SIV infection
leads to preferential CD4
 
  
 
T cell depletion in mucosal-
associated lymphoid tissue compared with peripheral blood
(6, 22, 23, 30), and early evidence suggests this holds for
HIV infection (16, 24–26), we initially examined how HIV
infection affects CD4
 
  
 
T cell depletion in the GI tract,
LNs, and peripheral blood by simple analysis of CD4
 
  
 
T
cell percentages in each tissue (Fig. 1). As expected, the fre-
quencies of CD4
 
  
 
T cells from HIV-infected individuals
were significantly lower compared with HIV-uninfected
individuals in each anatomical compartment (Fig. 1 A).
We did not find that 
 
   
 
T cells affected the frequencies
of CD4
 
  
 
or CD8
 
  
 
   
 
T cells in the GI tract. Indeed, their
frequencies were always 
 
 
 
10% of the total T cells, consis-
tent with previous reports in humans (unpublished data;
reference 31).
Although the lower percentages of CD4
 
  
 
T cells in the
GI tract of HIV-infected individuals (Fig. 1 B) are certainly
consistent with preferential depletion in this compartment,
preferential depletion cannot be established by simply com-
paring percentages of CD4
 
  
 
T cells in each compartment
because the GI tract of HIV-uninfected individuals also
contained significantly lower percentages of CD4
 
  
 
T cells
compared with either peripheral blood or LNs (Fig. 1 C).
Nonetheless, we were able to show that there is not only
extensive depletion of CD4
 
  
 
T cells, but also preferential
depletion of particular CD4
 
  
 
T cell subsets, including those
specifically targeted by HIV in the GI tract, in the studies
described next.
 
Endoscopic and Histological GI Tract Examination Suggests
Profound CD4
 
  
 
T Cell Depletion.
 
In these studies we
sought additional measures of relative population sizes. In
the GI tract we evaluated lymphoid tissue populations by
endoscopy and immunohistology. Such analysis of subject
Figure 1. CD4  T cell percentages in the GI tract, LNs, and peripheral
blood. Lymphocytes from HIV  (A and B) and HIV  (A and C) individuals
obtained from the blood, LNs, and GI tract were stained with anti-CD3
and anti-CD4 antibodies. The percentage of T cells that express CD4
represents lymphocyte and CD3  gated events that stain positively with
anti-CD4. p-values represent the results of Mann-Whitney statistical sig-
nificance calculations between sample cohorts (HIV  compared with
HIV ) or the results of Wilcoxon matched pairs for comparisons among
compartments for individual cohorts. 
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1421 (an HIV-uninfected individual) shows the typical
gross anatomical appearance of terminal ileum with large
lymphoid aggregates clearly apparent (Fig. 2 A). Similar
lymphoid aggregates were observed in all seven healthy in-
dividuals. However, in subject 1329 (an acute HIV sero-
converter) the terminal ileum is striking in its almost com-
Figure 3. CCR5 expression by T
cells in the GI tract, LNs, and periph-
eral blood. GI tract, LN, and periph-
eral blood lymphocytes from subject
1425 (A and B, HIV ) and 1428 (C
and D, HIV ) were stained with
anti-CD3, anti-CD4, anti-CD8, and
anti-CCR5 antibodies. Plots repre-
sent lymphocyte, CD3 , and either
CD4  or CD8  gated events. Values
indicate the calculated percentage of
memory CD4  or CD8  T cells that
express CCR5 as described in Mate-
rials and Methods.
Figure 2. Endoscopic and his-
tological analysis of the GI tract.
Endoscopic photographs from
subjects 1421 (A) and 1329 (B)
were obtained by passing the
colonoscope past the ileo–cecal
junction into the terminal ileum.
Immunohistological staining for
CD4 was performed by section-
ing biopsies from ileal lymphoid
tissue, and then hematoxylin and
eosin staining followed by stain-
ing for CD4 (C and D). 
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plete absence of discernible lymphoid tissue (Fig. 2 B).
Indeed, the histological staining for CD4 confirmed the
marked depletion of CD4
 
  
 
T cells (Fig. 2 D; CD8
 
  
 
T cells
remained abundant; not depicted). Similar patterns were
observed with the other subjects in our cohort; however,
because CD4
 
  
 
T cell populations are so spatially dispersed
in the GI tract, we were unable to count sufficient numbers
of cells in the small biopsies to accurately quantify the size
of the total CD4
 
  
 
T cell population. Nonetheless, these en-
doscopic and histologic analyses strongly suggested that
CD4
 
  
 
T cell depletion in the GI tract might be substantial
even at very early stages of HIV infection.
 
CCR5
 
  
 
CD4
 
  
 
T Cells Are Preferentially Depleted in the GI
Tract.
 
Although the endoscopic observations were strik-
ing, they could be considered anecdotal in isolation. There-
fore, we sought to address CD4  T cell depletion in
each compartment more quantitatively, and investigate one
mechanism for depletion related to target cell availability.
We examined the frequency of CCR5  CD4  T cells and
compared this with the frequency of CD8  T cells (Fig. 3).
In HIV-uninfected individuals, virtually all ( 95%) CD8 
T cells in the GI tract expressed CCR5, whereas more than
half of the GI tract CD4  T cells expressed the HIV core-
ceptor (the raw data for one such individual are shown in
Fig. 3, A and B), confirming previous reports (3, 4, 6). In
contrast, only 5–10% of LNs and 10–30% of peripheral
blood CD4  and CD8  T cells expressed CCR5, respec-
tively (Fig. 3, A and B). In an HIV-infected, treatment-
naive individual (1428; Fig. 3, C and D) and in four other
HIV-infected individuals (1416, 1419, 1431, and 1431), we
found a preferential and substantial depletion of GI tract
CCR5  CD4  T cells, consistent with data found using SIV
infection (6, 32). This depletion was specific to CD4  T
cells as all GI tract CD8  T cells maintained CCR5 expres-
sion (Fig. 3 D). Importantly, the nearly complete depletion
of CCR5  CD4  T cells was restricted to the GI tract. The
percentage of CCR5  CD4  T cells in LNs and peripheral
blood from HIV-infected individuals did not differ from
those in HIV-uninfected individuals (Fig. 3). This was sur-
prising, as immune activation, altered trafficking, and prolif-
eration per se should result in accumulation of CCR5 
CD4  and CD8  T cells in peripheral blood (33), LNs, and
GI tract. Although this was clearly the case for CD8  T
cells, CCR5  CD4  T cells do not appear to be elevated.
Furthermore, as we next show and later discuss, Ki67 
CD4  T cell frequency is not elevated in the GI tract.
Figure 4. Ki67 expression by memory T
cells in the GI tract, LNs, and peripheral blood.
Lymphocytes from HIV  (A, B, E, and F) and
HIV  (C–F) individuals obtained from the pe-
ripheral blood, LNs, and GI tract were stained
extracellularly with anti-CD3, anti-CD4 anti-
bodies, and anti-CD8 antibodies followed by
intracellular staining with anti-Ki67. The calcu-
lated percentage of memory T cells that express
Ki67 represents lymphocyte gated, CD3 , and
either CD4  or CD8  gated events that stain
positively with anti–Ki67 and were then ex-
pressed as the percentage of memory CD4  or
CD8  T cells as described in Materials and
Methods.HIV Pathogenesis in GI Tract, Lymph Nodes, and Blood 754
Taken together, the lack of expansion of activated CD4  T
cells and the preferential depletion of the CCR5  CD4  T
cells in the GI tract could be the result of the different bal-
ance in lymphoid tissue compartments between target cell
availability and death that reduce the numbers of these cells,
and the recruitment and expansion of this subset.
Different Activation Status of T Cells in the GI Tract, LNs,
and Peripheral Blood. It is well established that HIV-
infected individuals contain higher percentages of acti-
vated T cells compared with uninfected individuals based
on expression of a number of activation markers (34, 35),
and that activated CD4  T cells are the principal host cell
in which virus replicates over much of the long course of
infection (36). If HIV replicates in and causes the death
mainly of activated CCR5  CD4  T cells, one might ex-
pect to see preferential depletion of such cells in the GI
tract compared with other compartments based on their
availability. We found that this was the case by comparing
activation of T cell subsets in the peripheral blood, GI
tract, and LNs by measuring expression of the nuclear an-
tigen Ki67 (Fig. 4). In HIV-uninfected individuals, we
found that the GI tract contained a significantly higher
proportion of Ki67  T cells compared with either LNs or
peripheral blood (Fig. 4, A and B), in contrast to HIV-
infected individuals where no one compartment contained
a significantly higher proportion of either Ki67  CD4  or
CD8  T cells compared with any other compartment (Fig.
4, C and D). Consistent with immune activation in HIV
infection, with the exception of the CD4  T cells in the
GI tract, both CD8  and CD4  T cells from HIV-infected
individuals contained significantly higher proportions of
Ki67  T cells in every compartment examined. Ki67 ex-
pression by CD4  T cells in GI tract of HIV-infected indi-
viduals was not increased compared with HIV-uninfected
individuals (Fig. 4, E and F). This finding is consistent
with the hypothesis that activated CCR5  CD4  T cells in
the GI tract are continually depleted by ongoing infection
by HIV. Furthermore, as we later discuss, the rapid deple-
tion of the majority of GI tract CD4  T cells that occurs
during the acute phase of infection might be perpetuated
in the chronic phase by a failure of immune reconstitution
in this compartment.
Effector–Memory T Cells (TEM Cells) Accumulate Abnormally
in HIV  LNs. One hypothesis that readily accounts for
the abnormally high levels of activated T cells we observed
in LNs is that these cells reflect a general state of immune
activation and recruitment of T cells to a site of ongoing
viral replication. Because LNs are the site where virus is
replicating, rather than peripheral tissues, we also hypothe-
sized that effector-type T cells would be recruited to LNs,
reversing the usual migration of activated T cells from LNs
to peripheral tissues (37). We tested this hypothesis by ex-
amining expression patterns of CD27 and CD45RO that
define at least three different T cell subsets (Fig. 5). Such
distinct T cell subsets are not found in the GI tract samples,
but T cells generally conform to a “memory” phenotype
(unpublished data). The population that lacks CD27 ex-
pression represents a population of “effector” T cells (38)
or TEM cells (37). We found a significantly higher propor-
tion of CD27  CD4  and CD27  CD8  T cells from HIV-
infected individuals compared with HIV-uninfected indi-
viduals in peripheral blood and LNs (Fig. 6, A–D).
HIV-specific T Cells Do Not Account for all TEM Cells in
LNs. We then determined the contribution of HIV-spe-
cific T cells to the increase in the LN TEM cell population
by intracellular cytokine staining after HIV peptide stimu-
lation of LN and peripheral blood lymphocytes (Fig. 7).
Consistent with previous reports, we found only a low fre-
quency of HIV-specific CD4  T cells in both compart-
ments (29, 39, 40). However, we found detectable CD8 
T cells specific for multiple HIV antigens in LNs and pe-
ripheral blood (Fig. 7). In contrast to previous studies, we
found that responses directed against particular HIV gene
products in LNs were consistently found in peripheral
blood; however, several individuals produced peripheral
blood responses against specific HIV antigens that were
clearly absent in LNs. These data suggest that the pe-
ripheral blood contains a greater breadth of HIV-specific
Figure 5. Naive, central memory,
and TEM cell populations in LNs and
peripheral blood. LN and peripheral
blood lymphocytes from subject
1425 (HIV ) and 1413 (HIV ) were
stained with anti-CD4, anti-CD8,
anti-CD45RO, and anti-CD27 anti-
bodies. Plots represent lymphocyte
and either CD4   or CD8   gated
events.Brenchley et al. 755
CD8  T cells compared with LNs. Importantly, the HIV-
specific CD8  T cell populations were not of sufficient
magnitude to account for all CD8  TEM cells in the LNs of
HIV-infected individuals (Figs. 6 and 7). As our functional
assay is likely to underestimate the frequency of HIV-spe-
cific CD8  T cells (40), in two individuals we performed
tetramer staining for defined immunodominant epitopes
that allowed us to determine the frequency of such CD8 
T cells independent of function. These epitopes were se-
lected because they are frequently immunodominant and
encompass the majority of HIV-specific CD8  T cells (40,
41). In subject 1429 (HLA-A2 , HLA-B57 ) we exam-
ined the frequency of CD8  T cells binding tetramers
against the HLA-A2–restricted SLYTNVATL and the
HLA-B57–restricted KAFSPEVIPMF epitopes. In this in-
dividual, a total of 0.84% of LN CD8  T cells bound cor-
responding tetramers, whereas 3.6% of the CD8  T cells in
LNs were TEM. Similarly, in subject 1431 (HLA-A2 ,
Figure 6. TEM cells and collagen deposition
in LNs. Percentages of LN (A and B) and pe-
ripheral blood (C and D) CD4  and CD8  TEM
cell populations were determined based upon
expression patterns of CD27 and CD45RO.
Collagen deposition levels were calculated as
described in Materials and Methods and were
then compared with percentage of CD4  (E) or
CD8  T cells (F) of the TEM phenotype.
Figure 7. HIV-specific CD8 
T cells in LNs and peripheral
blood. Lymphocytes from HIV 
individuals obtained from pe-
ripheral blood and LNs were
stimulated with overlapping HIV
peptides for gag, pol, and env,
and costimulatory antibodies as
described in Materials and Meth-
ods. Lymphocytes were then ex-
tracellularly stained with anti-
CD3, anti-CD4, and anti-CD8
antibodies followed by intracel-
lular staining with anti–IL-2 and
anti–IFN-  antibodies. The percentage of memory CD8  T cells that are HIV specific was determined after lymphocyte, CD3 , and CD8  gating
followed by adjustment based upon the percentage of memory CD8  T cells for each individual as described in Materials and Methods. Bars represent
the frequency of memory CD8  T cells that respond to pol, (red bars) gag (white bars), or env (black bars).HIV Pathogenesis in GI Tract, Lymph Nodes, and Blood 756
HLA-B8 ) a total of 2.1% of LN CD8  T cells bound tet-
ramers corresponding to HLA-A2–restricted SLYTNVATL
and HLA-B8–restricted GGKKKYKL and FLKEKGGL
epitopes, whereas 4.6% of CD8  T cells in LNs were TEM.
Therefore, the functional and physical analyses of LN
HIV-specific CD8  T cell frequency suggest that not all
TEM cells are HIV specific.
Immune Activation Correlates with Collagen Deposition in
LNs. The increased numbers of activated T cells and TEM
cells in LNs of HIV-infected patients is consistent with the
hypothesis that such increases reflect the in situ generation
of these cells as well as their activation and recruitment to a
site of active viral replication. We have also previously doc-
umented increased deposition of collagen in LNs, which
we attributed to the inflammation associated with chronic
immune activation. Because this would be a pathological
process parallel to the increases in TEM cells, we looked for
and found a significant positive correlation between LN
collagen and percentage of TEM cells in LNs (Fig. 6, E and
F). Consistent with the hypothesis of such parallel processes
in LNs, these same correlations were not found with pe-
ripheral blood TEM cells (not depicted).
Discussion
Much that is understood regarding CD4  T cell deple-
tion, heightened T cell activation states, T cell dynamics,
and HIV-specific T cells in HIV infection is derived from
the analysis of peripheral blood lymphocytes. Although the
importance of studies of how HIV infection affects lym-
phoid tissue is certainly appreciated (15, 42–44), there are
few and only very recent studies of the GI tract (8, 20, 21,
24) due to the difficulty in obtaining tissue samples. Sub-
stantial ground has been gained through the SIV rhesus
macaque model (5, 22, 23, 30). However, to date there
have been no reports comparing CD4  and CD8  T cell
populations in peripheral blood, GI tract, and LNs from
HIV-infected and -uninfected individuals.
From our current study, the following five major points
emerged: (a) the GI tract has the most substantial CD4  T
cell depletion at all stages of HIV disease; (b) this depletion
occurs preferentially within the CCR5  CD4  T cell sub-
set, which accounts for the majority of GI tract CD4  T
cells; (c) HIV-associated immune activation results in an
accumulation of effector/TEM cells within LNs; (d) HIV-
specific T cells residing in LNs do not, alone, account for
the inflammatory T cell response within HIV-infected
LNs; and (e) T cell activation in LNs is associated with col-
lagen deposition.
Quantitative analysis of CD4  T cell depletion in LNs
and the GI tract is substantially more challenging than in
peripheral blood. LNs and the GI tract are not homoge-
neous organs and histological sections sampled for analysis
may not be representative; therefore, other parameters
must be examined. Perhaps the most obvious variables to
quantify are either CD4 /CD8  T cell ratios or CD4  T
cell percentages by flow cytometry. Indeed, such analysis
suggests that the GI tract is substantially more depleted of
CD4  T cells than either peripheral blood (24) or LNs.
However, examination of the same anatomical compart-
ments from healthy individuals demonstrates that even un-
der normal circumstances, the GI tract contains a lower
percentage of CD4  T cells compared with either periph-
eral blood or LNs. Thus CD4  T cell percentages cannot
be used to estimate CD4  T cell depletion in tissue. There-
fore, we examined three other, independent parameters to
demonstrate that the GI tract was preferentially depleted of
CD4  T cells. Measurement of CCR5  CD4  and CD8 
T cells, endoscopic and histological examination of the GI
tract, and measurement of activated T cells in each com-
partment suggested that the GI tract was significantly de-
pleted of CD4  T cells compared with either peripheral
blood or LNs and that this occurred even at very early time
points after infection.
Interpretation of the changes in T cell subsets that differ
between lymphoid tissue compartments is complicated by
the nature of the analysis—“snap-shots” of tissues—and by
the potential mechanisms to explain these changes that in-
clude preferential infection and killing of T cell subsets, and
the redistribution, proliferation, activation-induced T cell
death, and alterations in the lymphoid tissue milieu that ac-
company immune activation. We believe that compart-
ment-specific variations in these processes account for the
differences we observed, particularly in the CD4  T cell
population in the GI tract.
The majority of GI tract CD4  T cells expresses CCR5
and comprises a higher frequency of activated T cells than
peripheral blood or LNs in HIV-uninfected individuals.
Thus, they represent ideal targets for HIV replication. It is
likely that direct infection of this population results in its
profound depletion during the acute phase of HIV disease.
Ongoing direct infection and sustained death might explain
the continued depletion of GI tract CCR5  CD4  T cells
that is only partially offset by proliferation of CD4  T cells
in the GI tract, and resulting in apparently normal levels of
CD4  T cell activation. On the other hand, in LNs, there
is a smaller proportion of activated CCR5  CD4  T cell
targets and thus proliferation and recruitment of CD4  T
cells might sufficiently exceed direct killing for the height-
ened state of immune activation to be evident in this com-
partment. In addition, it is possible that during the chronic
phase of the disease, the disruption of the homeostatic pro-
cesses that maintain total body T cell numbers (44) would
in itself hinder CD4  T cell reconstitution in lymphoid tis-
sue. The consequence of this would be particularly damag-
ing in the GI tract as, in contrast to LNs, there is only a
negligible resident naive CD4  T cell pool available to be-
come activated, expand, and supply the already profoundly
depleted memory CD4  T cell pool.
Alternatively, the decrease in the frequency of CCR5 
CD4  T cells in the GI tract in HIV infection might arise
from altered migration of activated CCR5  CD4  T cells
into the GI tract, or from recruitment of CCR5  CD4 
and CCR5  CD8  T cells to the GI tract. However, the
latter explanation requires specific infiltration of two unre-
lated T cell subsets, CCR5  CD8  T cells and CCR5 Brenchley et al. 757
CD4  T cells, even though total GI tract lymphoid tissue
appears to be dramatically decreased overall. Therefore, we
believe the most likely explanation is that direct infection
and killing, either by HIV or by HIV-specific T cells, of GI
tract CCR5  CD4  T cells leads to their profound deple-
tion in acute infection, and that this depletion is maintained
during the chronic phase of the disease. In addition, it is
possible that the few CCR5  CD4  T cells in GI tract that
persist represent resting CCR5  CD4  T cells that have
never seen antigen and might be resistant to HIV-mediated
lysis (45, 46). Importantly, we chose to biopsy terminal il-
eum as this site has the greatest concentration of GI tract T
cells. Although our samples contained a combination of
lamina propria and Peyer’s patch lymphoid tissue, the ma-
jority of our biopsies contained a low frequency of naive T
cells, suggesting that they consisted predominantly, but not
exclusively, of lamina propria. Because we cannot distin-
guish between these lymphoid compartments, it is possible
that CD4  T cell depletion is more substantial in lamina
propria compared with Peyer’s patches, and we may have
observed more dramatic CD4  T cell depletion if we had
also biopsied jejunum or colon, which lack Peyer’s patches
(45–47). Hence, we may have even underestimated the ex-
tent of CD4  T cell depletion from the entire GI tract.
It has been suggested that immune activation associated
with HIV infection would lead to increased percentages of
CCR5  CD4  T cells in peripheral blood, as seen in acute
EBV infection (33). However, although HIV-infected in-
dividuals contain increased frequencies of peripheral blood
CCR5  CD8  T cells, a corresponding increase in periph-
eral blood CCR5  CD4  T cells is not observed. One ex-
planation for this observation is that there might be redistri-
bution of CCR5  CD4  T cells from peripheral blood to
LNs or GI tract in HIV infection (48–50). However, upon
examination of CD4  T cells in the LNs and GI tract, we
found no increases in CCR5  CD4  T cell percentages.
Therefore, we believe our data suggest that accumulation
of CCR5  CD4  T cells resulting from immune activation
associated with HIV infection is offset by their preferential
death rather than redistribution, whereas activated CD8  T
cells accrue. Importantly, as the percentage of infected pe-
ripheral blood CD4  T cells is usually  1% in chronic in-
fection (39, 51), it seems unlikely that direct infection of
activated CD4  T cells is solely responsible for the death of
CCR5  CD4  T cells, and other factors likely contribute.
Taken together, the findings of substantial CD4  T cell de-
pletion in the GI tract and lack of evidence for redistribu-
tion to LNs, suggest that peripheral blood CD4  T cell
counts may actually underestimate the degree of overall T
cell depletion in acute and chronic HIV infection.
Another mechanism contributing to the loss of CD4  T
cells in HIV infection is likely to involve disturbance of
normal lymphoid tissue homeostatic processes. Peripheral
LNs are structurally organized to promote interaction be-
tween antigens, chemokines, growth factors, and lympho-
cytes to generate an immunologic response and maintain
populations of CD4  and CD8  T cells (52). It is likely that
the inflammation and tissue remodeling that accompany lo-
cal innate and adaptive immune responses to HIV replica-
tion lead to destruction of LN architecture observed in
HIV disease (28), which, because of the particular depen-
dency of CD4  T cells on the LN milieu (53), contributes
to decreased survival and depletion of the CD4  T cell sub-
set. We interpret our data on the sequestration or retention
of TEM cells that are not normally found in LNs as evidence
of the chronic proinflammatory responses generated as a re-
sult of ongoing viral replication in the LN. Furthermore, B
cell activation, characterized by germinal center hyperpla-
sia, might add to LN architectural damage. Importantly,
trafficking of T cells to the follicular dendritic cell network
is likely to depend on an intact LN architecture, and such
trafficking might be consequently impaired in a fibrosed
LN. Hence, what was an organ of antigen presentation and
homeostasis in health becomes an organ of inflammation
and fibrosis in HIV infection. Furthermore, our data con-
tinue to suggest that in individuals with significant LN col-
lagen deposition, there might be therapeutic benefit from
antiinflammatory and/or antifibrotic agents, singly or in
combination with antiretroviral therapy, to prevent further
or reduce LN damage.
Finally, our data also demonstrate that the majority of
TEM cells sequestered to or retained in LNs are not HIV spe-
cific. One possibility is that they are elicited by subclinical
opportunistic infections secondary to the immunosuppres-
sive effects of HIV infection (46). In fact, the LNs actually
had a smaller breadth of HIV-specific T cells compared with
peripheral blood, suggesting that HIV-specific T cells are
not preferentially recruited to LNs. Indeed, although we
have not determined the cytotoxic capacity of HIV-specific
T cells in LNs against the resident viral quasispecies, the low
frequency of T cells responding at a major site of virus repli-
cation may point to one more example of the failure of im-
mune defenses in fully controlling HIV replication.
The results also imply that LNs are not a continuous
source of peripheral blood HIV-specific T cells. Moreover,
the breadth of HIV-specific T cells was not the only vari-
able we measured that differed between anatomical com-
partments. There was no clear correlation between the GI
tract, LNs, and peripheral blood for any of the parameters
we measured. Hence, data obtained from peripheral blood
cannot be used to predict or model immunological pro-
cesses or HIV pathogenesis in the GI tract or LNs, and such
compartments should be directly sampled and studied.
The substantial depletion of GI tract CCR5  CD4  T
cells implies that total body CD4  T cell numbers are se-
verely reduced, even in very early infection. This, by itself,
would impose a considerable homeostatic strain on the
maintenance of the memory CD4  T cell pool. Immune
activation that defines the chronic phase of the infection
results in destruction of lymphoid tissue architecture that,
in turn, impacts upon the ability of lymphoid tissue to sup-
port normal lymphocyte homeostasis and antigen presenta-
tion. Taken together, our data suggest that HIV infection
directly and indirectly causes damage to many immune
compartments and a combination of such deleterious ef-
fects ultimately leads to immune failure and AIDS. Under-HIV Pathogenesis in GI Tract, Lymph Nodes, and Blood 758
standing the relative contribution of each of the factors that
we have described can provide a rational framework upon
which future therapeutic interventions can be based.
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